• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493919920300
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Reocclusion (1985)
Event Date 02/09/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the complaint device was not received for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that unstable angina and in-stent restenosis occurred.In (b)(6) 2013 the subject presented with stable angina (ccs classification: 2) and was referred for cardiac catheterization.Target lesion #1 was located in the proximal left anterior descending artery (lad) with 80% stenosis and was 16 mm long with a reference vessel diameter of 3.0 mm.Target lesion #1 was treated with pre-dilatation and placement of 3.00 x 20 mm study stent with 0% residual stenosis.In (b)(6) 2013, the subject was discharged on dual antiplatelet therapy.In (b)(6) 2018, 1715 the subject was admitted due to recurrent chest pain and syncope.The subject also stated that he had frequent episodes of palpitation and nausea.The subject¿s symptoms were assessed as unstable angina with ccs iii.On admission, electrocardiogram (ecg) revealed deep t wave inversion in the precordial leads (v2-v6) and these changes were new.Cardiac markers were normal.The subject was referred for coronary angiography for further evaluation.The 90% in-stent restenosis in proximal lad was treated with the placement of a 3.0 x 12 mm synergy¿ stent with 0% residual stenosis and timi 3 flow.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7664510
MDR Text Key113257586
Report Number2134265-2018-05896
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 06/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/05/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/09/2013
Device Model NumberH7493919920300
Device Lot Number15671416
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/13/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/27/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-